课题基金 / 基金详情

DCS - An investigation to enhance immunity to influenza in elderly individuals through reversal of the immune senescence

DCS - An investigation to enhance immunity to influenza in elderly individuals through reversal of the immune senescence
DCS - 一项通过逆转免疫衰老来增强老年人流感免疫力的研究
批准号:
G1000622/1
负责人:
Paul Moss
金额:
$112.68万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

Paul Moss的其他基金

相似基金

相关文献

中文摘要
翻译
流感是一个主要的健康问题,虽然每年都给60岁以上的人接种流感疫苗,但很多人对疫苗的免疫反应很差。现在很清楚,老年人免疫系统可能出现问题的一个原因是他们携带慢性病毒感染,如巨细胞病毒(CMV)。免疫系统必须非常努力地工作来控制这些感染,这是什么?转移注意力我们建议使用抗病毒药物,通常用于治疗感冒疮等疾病,以抑制CMV,从而使免疫系统从对抗病毒中恢复过来。我们预计,免疫反应的效率,然后将提高,并作出更强的反应,流感疫苗接种.在研究的第一部分,我们将找到片剂的剂量,这是最有效的这种效果,看看多久需要采取.在第二部分中,我们将在正在接受流感疫苗的大型老年供体队列中使用该剂量。因此,我们将测试这种干预是否有效。如果得到证实,这种形式的治疗在广泛的临床条件下可能是有价值的,并有助于促进健康的老龄化。
英文摘要
Flu is a major health concern and although flu vaccination is given every year to people over the age of 60 years, a lot of people make a poor immune response to the vaccine. It is now clear that one reason why older people can develop problems with their immune system is that they carry chronic viral infections such as cytomegalovirus (CMV). The immune system has to work very hard to control these infections and this ?diverts? them away from new infections such as flu.We propose to use anti-viral drugs, that are often used to treat diseases such as cold sores, to dampen down CMV and therefore allow the immune system to recover from fighting the virus. We anticipate that the efficiency of the immune response will then improve and make a stronger response to flu vaccination.In the first part of the study we will find the dose of tablet that is most effective in this effect and see how long it needs to be taken for. In a second section we will use this dose in a large cohort of elderly donors who are receiving their influenza vaccine. We will therefore test if this intervention is effective. If proven, this form of treatment could be valuable in a wide range of clinical conditions and help to promote healthy ageing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 COVID-19 Immunity - National Core Study
  • 批准号:
    MC_PC_20060
  • 项目类别:
    Intramural
  • 资助金额:
    $999.65万
  • 财政年份:
    2021
  • 负责人:
    Paul Moss
  • 依托单位:
COVID-19 Immunity - National Core Study (IMM-NCS)
  • 批准号:
    MC_PC_20031
  • 项目类别:
    Intramural
  • 资助金额:
    $917.42万
  • 财政年份:
    2020
  • 负责人:
    Paul Moss
  • 依托单位:
A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
  • 批准号:
    MR/V028448/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $838.0万
  • 财政年份:
    2020
  • 负责人:
    Paul Moss
  • 依托单位:
University of Birmingham - Proximity to Discovery 2017
  • 批准号:
    MC_PC_17183
  • 项目类别:
    Intramural
  • 资助金额:
    $25.7万
  • 财政年份:
    2018
  • 负责人:
    Paul Moss
  • 依托单位:
海外基金